Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study (BEMIDIA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03000049|
Recruitment Status : Unknown
Verified December 2016 by Sven-Olaf Kuhn, University Medicine Greifswald.
Recruitment status was: Recruiting
First Posted : December 21, 2016
Last Update Posted : December 22, 2016
With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobial therapy in patients with sepsis and septic shock.
Prospective observational, open-label mono-center study to compare a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System and Curetis Univero System) with standard blood culture diagnostics in patients with sepsis or septic shock.
|Condition or disease||Intervention/treatment|
|Sepsis Septic Shock||Other: bedside blood culture|
|Study Type :||Observational|
|Estimated Enrollment :||500 participants|
|Official Title:||Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study|
|Study Start Date :||November 2016|
|Estimated Primary Completion Date :||July 2017|
|Estimated Study Completion Date :||September 2017|
- Time to a significant change of antimicrobial therapy from the time of the diagnosis of sepsis or septic shock [ Time Frame: Nov. 2016 - Nov. 2017 ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03000049
|Contact: Matthias Gründling, MDfirstname.lastname@example.org|
|Anesthesiology and Intensive Care Medicine Department, University of Greifswald, Germany||Recruiting|
|Greifswald, Germany, 17475|
|Contact: Sven-Olaf Kuhn, MD 3834507952 email@example.com|
|Contact: Matthias Gründling, MD|
|Principal Investigator: Matthias Gründling, MD|